Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and Joan's Legacy
Hayley McDaid, PhD
Albert Einstein College of Medicine
New York
NY
Two commonly mutated genes in non-small cell lung cancer are KRAS and BRAF. Dr. McDaid is studying how these two genes control the synthesis of proteins in lung cancer cells. She is also testing how targeting the LKB1 mutation that often co-occurs with KRAS mutations can neutralize the effects of the KRAS mutation.